Ingevity Corporation NGVT
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.13B | 1.16B | 1.18B | 1.17B | 1.18B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.13B | 1.16B | 1.18B | 1.17B | 1.18B |
| Cost of Revenue | 656.30M | 683.20M | 711.80M | 706.20M | 702.30M |
| Gross Profit | 476.00M | 477.10M | 465.90M | 461.40M | 473.60M |
| SG&A Expenses | 159.40M | 165.40M | 170.00M | 171.20M | 167.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 844.20M | 875.80M | 909.90M | 905.80M | 897.80M |
| Operating Income | 288.10M | 284.50M | 267.80M | 261.80M | 278.10M |
| Income Before Tax | 44.50M | 37.80M | -149.50M | -142.10M | -12.70M |
| Income Tax Expenses | 9.00M | 12.60M | 6.50M | 8.20M | 39.30M |
| Earnings from Continuing Operations | 35.50 | 25.20 | -156.00 | -150.30 | -52.00 |
| Earnings from Discontinued Operations | 24.30M | 28.80M | 28.20M | -16.80M | -13.90M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.80M | 54.00M | -127.80M | -167.10M | -65.90M |
| EBIT | 288.10M | 284.50M | 267.80M | 261.80M | 278.10M |
| EBITDA | 378.20M | 382.60M | 370.60M | 368.10M | 395.80M |
| EPS Basic | 1.78 | 1.54 | -3.49 | -4.62 | -1.79 |
| Normalized Basic EPS | 3.72 | 3.51 | 2.14 | 1.93 | 1.81 |
| EPS Diluted | 1.70 | 1.46 | -3.55 | -4.66 | -1.83 |
| Normalized Diluted EPS | 3.65 | 3.45 | 2.11 | 1.91 | 1.79 |
| Average Basic Shares Outstanding | 139.91M | 141.96M | 143.77M | 144.89M | 145.49M |
| Average Diluted Shares Outstanding | 141.85M | 143.95M | 145.17M | 145.82M | 146.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |